Axq Capital, LP Exelixis, Inc. Transaction History
Axq Capital, LP
- $428 Billion
- Q2 2024
A detailed history of Axq Capital, LP transactions in Exelixis, Inc. stock. As of the latest transaction made, Axq Capital, LP holds 59,629 shares of EXEL stock, worth $1.52 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
59,629
Previous 13,000
358.68%
Holding current value
$1.52 Million
Previous $308 Million
334.33%
% of portfolio
0.31%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding EXEL
# of Institutions
460Shares Held
240MCall Options Held
2.04MPut Options Held
1.29M-
Black Rock Inc. New York, NY33.5MShares$857 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.7MShares$758 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA27.1MShares$693 Million2.95% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.2MShares$388 Million0.6% of portfolio
-
State Street Corp Boston, MA12.6MShares$322 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $8.23B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...